Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CMA Stock Summary
Top 10 Correlated ETFs
CMA
In the News
Should You Watch Comerica (CMA) for Its Solid Dividend Yields?
Investors may consider attractive dividend-yielding stocks like Comerica (CMA) for their portfolios amid the current economic uncertainties.
Comerica (CMA) Thrives on Loan Growth Amid Rising Expenses
Comerica (CMA) gains from steady loan growth and strategic restructuring initiatives. Yet, rising costs, along with a lack of loan portfolio and geographical diversification, are headwinds.
5 Top Dividend Stocks Passive Income Investors Should Buy in March
Sponsored: Tips for Investing A financial advisor can help you understand the advantages and disadvantages of investment properties.
Dividend Stocks That Could Deliver Life-Changing Returns
2022 was a dreadful year for investors, with the S&P 500 down almost 20% and the Nasdaq lower by a stunning 33%.
Can Comerica Stock Topple Pesky Resistance?
Shares of Comerica Incorporated (NYSE:CMA) are up 0.3% at $50.36 at last check, and added 54.1% over the last nine months.
Three-Stock Lunch: Meta, Comerica and McDonald's
Scott Nations, Nations Indexes founder, joins 'Power Lunch' to discuss three stocks; Meta, Comerica and McDonald's.
Comerica's Cash Flow Increases The Safety Of Its Dividend Yield
Comerica has increased its regular dividend from $0.30/share in 1Q18 to $0.71/share in 3Q23. The current quarterly dividend, when annualized, equals $2.84/share and provides a 5.3% dividend yield.
3 Bank Stocks You Need to Sell Immediately
The sector might be set for a resurgence after a tough year for bank stocks that included multiple meltdowns, like Silicon Valley Bank. Banking indices climbed in 2023's latter half and seem to maintain that momentum today.
Not all regional banks are created equal, says Jim Cramer
'Mad Money' host Jim Cramer talks the state of regional banks and investing opportunities in the sector.
Comerica's (CMA) Q4 Earnings Beat Estimates, NII Declines Y/Y
A decline in revenues and higher expenses affect Comerica's (CMA) Q4 earnings. Nonetheless, a fall in provisions on a year-over-year basis offers some support.
CMA Financial details
CMA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 22.29 | 20.95 | 21.98 | 26.98 | 40.11 | |
Net income per share | 7.99 | 3.58 | 8.65 | 8.79 | 6.67 | |
Operating cash flow per share | 7.27 | 6.68 | 4.7 | 4.87 | 9.48 | |
Free cash flow per share | 6.69 | 6.11 | 4.18 | 4.24 | 8.32 | |
Cash per share | 122.47 | 222.78 | 295.27 | 194.28 | 80.99 | |
Book value per share | 48.85 | 57.91 | 58.5 | 39.55 | 48.53 | |
Tangible book value per share | 44.6 | 588.24 | 49.04 | 29.61 | 43.72 | |
Share holders equity per share | 48.85 | 57.91 | 58.5 | 39.55 | 48.53 | |
Interest debt per share | 52.05 | 49.03 | 27.63 | 49.17 | 79.84 | |
Market cap | 10.76B | 7.76B | 11.75B | 8.76B | 7.37B | |
Enterprise value | 12.28B | -2.27B | -8.14B | 8.71B | 7.64B | |
P/E ratio | 8.98 | 15.62 | 10.06 | 7.61 | 8.36 | |
Price to sales ratio | 3.22 | 2.67 | 3.96 | 2.48 | 1.39 | |
POCF ratio | 9.87 | 8.37 | 18.53 | 13.73 | 5.89 | |
PFCF ratio | 10.72 | 9.15 | 20.82 | 15.75 | 6.71 | |
P/B Ratio | 1.47 | 0.96 | 1.49 | 1.69 | 1.15 | |
PTB ratio | 1.47 | 0.96 | 1.49 | 1.69 | 1.15 | |
EV to sales | 3.67 | -0.78 | -2.74 | 2.46 | 1.44 | |
Enterprise value over EBITDA | 7.46 | -3.25 | -5.12 | 4.91 | -1.91K | |
EV to operating cash flow | 11.27 | -2.45 | -12.84 | 13.65 | 6.1 | |
EV to free cash flow | 12.24 | -2.68 | -14.43 | 15.67 | 6.95 | |
Earnings yield | 0.11 | 0.06 | 0.1 | 0.13 | 0.12 | |
Free cash flow yield | 0.09 | 0.11 | 0.05 | 0.06 | 0.15 | |
Debt to equity | 1 | 0.82 | 0.47 | 1.2 | 1.53 | |
Debt to assets | 0.1 | 0.08 | 0.04 | 0.07 | 0.11 | |
Net debt to EBITDA | 0.92 | -14.36 | -12.51 | -0.03 | -67.25 | |
Current ratio | 335.23 | 40.8 | 52.57 | 9.74 | 0.32 | |
Interest coverage | 3.27 | 3.25 | 26.14 | 8.17 | -0.01 | |
Income quality | 0.91 | 1.96 | 0.54 | 0.55 | 1.42 | |
Dividend Yield | 0.04 | 0.05 | 0.03 | 0.04 | 0.05 | |
Payout ratio | 0.34 | 0.77 | 0.34 | 0.33 | 0.45 | |
Sales general and administrative to revenue | 0.31 | 0.36 | 0.39 | 0.35 | 0.26 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.08 | -0.09 | -0.11 | -0.13 | -0.12 | |
Capex to revenue | -0.03 | -0.03 | -0.02 | -0.02 | -0.03 | |
Capex to depreciation | -0.75 | -0.73 | -0.71 | -0.89 | -1.76 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
Graham number | 93.69 | 68.26 | 106.71 | 88.42 | 85.37 | |
ROIC | 0.08 | 0.03 | 0.1 | 0.11 | 0 | |
Return on tangible assets | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | -310.81 | 155.78 | -397.66 | -375.05 | -500.14 | |
Working capital | 23.73B | 36.02B | 45.23B | 28.07B | -21.51B | |
Tangible asset value | 6.69B | 81.77B | 7.26B | 4.55B | 5.77B | |
Net current asset value | -42.27B | 31.19B | -40.61B | -48.94B | -69.53B | |
Invested capital | 1 | 0.82 | 0.47 | 1.2 | 1.53 | |
Average receivables | 4.77B | 5.69B | 6.1B | 6.88B | 7.76B | |
Average payables | 22.5M | 460M | 861.5M | -19.57B | -20.01B | |
Average inventory | -2.99B | -11.04B | -19.56B | -11.51B | -3.27B | |
Days sales outstanding | 592.87 | 746.29 | 768.01 | 776.99 | 550.71 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.62 | 0.49 | 0.48 | 0.47 | 0.66 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.16 | 0.06 | 0.15 | 0.22 | 0.14 | |
Capex per share | -0.57 | -0.57 | -0.52 | -0.63 | -1.16 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.78 | 7.56 | 7 | 6.79 | 10.02 | |
Net income per share | 2.67 | 2.47 | 2.07 | 1.9 | 0.25 | |
Operating cash flow per share | 4.56 | 3.53 | -1.17 | -1.35 | 8.51 | |
Free cash flow per share | 4.37 | 3.37 | -1.42 | -1.64 | 8.05 | |
Cash per share | 194.23 | 224.3 | 212.33 | 188.17 | 81.05 | |
Book value per share | 39.54 | 45.76 | 42.39 | 37.67 | 48.57 | |
Tangible book value per share | 29.6 | 36.06 | 32.77 | 28.05 | 43.75 | |
Share holders equity per share | 39.54 | 45.76 | 42.39 | 37.67 | 48.57 | |
Interest debt per share | 48.61 | 140.01 | 128.58 | 86.08 | 75.32 | |
Market cap | 8.76B | 5.69B | 5.59B | 5.48B | 7.36B | |
Enterprise value | 8.71B | 13.05B | 11.89B | 8.23B | 7.63B | |
P/E ratio | 6.26 | 4.39 | 5.12 | 5.46 | 55.77 | |
Price to sales ratio | 8.59 | 5.75 | 6.05 | 6.12 | 5.57 | |
POCF ratio | 14.67 | 12.31 | -36.07 | -30.81 | 6.56 | |
PFCF ratio | 15.29 | 12.9 | -29.74 | -25.27 | 6.93 | |
P/B Ratio | 1.69 | 0.95 | 1 | 1.1 | 1.15 | |
PTB ratio | 1.69 | 0.95 | 1 | 1.1 | 1.15 | |
EV to sales | 8.54 | 13.19 | 12.87 | 9.19 | 5.78 | |
Enterprise value over EBITDA | 14.5 | 20.08 | 33.39 | 25.18 | 331.75 | |
EV to operating cash flow | 14.59 | 28.26 | -76.69 | -46.26 | 6.8 | |
EV to free cash flow | 15.21 | 29.6 | -63.23 | -37.94 | 7.18 | |
Earnings yield | 0.04 | 0.06 | 0.05 | 0.05 | 0 | |
Free cash flow yield | 0.07 | 0.08 | -0.03 | -0.04 | 0.14 | |
Debt to equity | 1.2 | 3.02 | 2.95 | 2.18 | 1.53 | |
Debt to assets | 0.07 | 0.2 | 0.18 | 0.13 | 0.11 | |
Net debt to EBITDA | -0.08 | 11.33 | 17.69 | 8.41 | 11.7 | |
Current ratio | 9.74 | 3.38 | 3.77 | 6.94 | 0.32 | |
Interest coverage | 4.33 | 2.61 | 0.79 | 0.65 | 6.26 | |
Income quality | 1.71 | 1.43 | -0.57 | -0.71 | 34 | |
Dividend Yield | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | |
Payout ratio | 0.27 | 0.29 | 0.36 | 0.39 | 3.12 | |
Sales general and administrative to revenue | 0.32 | 0.34 | 0.35 | 0.37 | 0.29 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.04 | -0.05 | 0.21 | 0.22 | -0.05 | |
Capex to revenue | -0.02 | -0.02 | -0.04 | -0.04 | -0.05 | |
Capex to depreciation | -1.14 | -1.05 | -1.5 | -1.77 | -2.61 | |
Stock based compensation to revenue | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | |
Graham number | 48.75 | 50.46 | 44.41 | 40.14 | 16.53 | |
ROIC | 0.04 | 0.02 | 0.01 | 0.02 | 0.04 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | -374.95 | -424.4 | -428.87 | -408.52 | -500.52 | |
Working capital | 28.07B | 26.19B | 26.48B | 28.57B | -21.51B | |
Tangible asset value | 4.55B | 4.72B | 4.33B | 3.7B | 5.77B | |
Net current asset value | -48.94B | -47.92B | -49.13B | -47.35B | -69.53B | |
Invested capital | 1.2 | 3.02 | 2.95 | 2.18 | 1.53 | |
Average receivables | 7.63B | 7.67B | 7.92B | 8.28B | 8.27B | |
Average payables | -19.75B | -14.5B | 10.25B | 7.15B | 2.37B | |
Average inventory | -3.19B | -5.72B | -11.2B | -9.92B | -7.71B | |
Days sales outstanding | 663.79 | 711.45 | 780.49 | 858.21 | 544.29 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.14 | 0.13 | 0.12 | 0.1 | 0.17 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.07 | 0.05 | 0.05 | 0.05 | 0.01 | |
Capex per share | -0.18 | -0.16 | -0.25 | -0.3 | -0.45 |
CMA Frequently Asked Questions
What is Comerica Incorporated stock symbol ?
Comerica Incorporated is a US stock , located in Dallas of Tx and trading under the symbol CMA
Is Comerica Incorporated buy or a sell ?
24 stock analysts have 24 predictions with a medium analyst target price of $92.44. The lowest prediction is $47.24 and the highest is $118
What is CMA stock prediction ?
What is Comerica Incorporated stock quote today ?
Comerica Incorporated stock price is $54.23 today.
Is Comerica Incorporated stock public?
Yes, Comerica Incorporated is a publicly traded company.